This report aims to address the promise of Al-powered predictive analytics for the pharma sector. It highlights the importance of integrating various internal and external data that impact brand performance. Opportunities for market-driven and real-time segmentation of customers allow companies to orchestrate and measure their brands’ commercial tactics. These insights can help commercial teams evaluate their current digital 1Q, and assess their opportunities more effectively than ever before. They serve as a roadmap to setting up new tools to measure and personalize their engagement with HCPs, with precision and a positive impact on the bottom-line.